Illumina (NASDAQ:ILMN) Receives Overweight Rating from Stephens
Stephens restated their overweight rating on shares of Illumina (NASDAQ:ILMN – Free Report) in a research note released on Tuesday,Benzinga reports. Stephens currently has a $105.00 target price on the life sciences company’s stock. ILMN has been the subject of a number of other reports. Hsbc Global Res lowered Illumina from a “strong-buy” rating to […]
